📣 VC round data is live. Check it out!

MicroPort Scientific Valuation Multiples

Discover MicroPort Scientific's revenue and EBITDA valuation multiples and investment history, alongside public comparables like NovoCure, AddLife, Bausch Health, MicroPort and more.

MicroPort Scientific Overview

About MicroPort Scientific

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacturing, & R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacturing, R&D of orthopedics devices. CRM business: sales, manufacturing, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacturing, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacturing, R&D of neurovascular devices. Structural heart disease business: sales, manufacturing, R&D of heart valve devices. Surgical robot business: sales, manufacturing, & R&D of surgical robot devices. Surgical devices business: sales, manufacturing, R&D of surgical devices.


Founded

1998

HQ

China

Employees

6.3K

Financials (LTM)

Revenue: $1B
EBITDA: $190M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

MicroPort Scientific Financials

MicroPort Scientific reported last 12-month revenue of $1B and EBITDA of $190M.

In the same LTM period, MicroPort Scientific generated $657M in gross profit, $190M in EBITDA, and $65M in net income.

Revenue (LTM)


MicroPort Scientific P&L

In the most recent fiscal year, MicroPort Scientific reported revenue of $1B and EBITDA of $159M.

MicroPort Scientific is profitable as of last fiscal year, with gross margin of 50%, EBITDA margin of 14%, and net margin of 4%.

See analyst estimates for MicroPort Scientific
LTMLast FY202320242025202620272028
Revenue$1B$1B$951M$1B$995M
Gross Profit$657M$554M$532M$574M$554M
Gross Margin58%50%56%56%56%
EBITDA$190M$159M($383M)$37M$24M
EBITDA Margin17%14%(40%)4%2%
EBIT Margin2%(2%)(39%)(11%)(5%)
Net Profit$65M$49M($478M)($214M)$49M
Net Margin6%4%(50%)(21%)5%
Net Debt-$867M---

Financial data powered by Morningstar, Inc.

MicroPort Scientific Stock Performance

MicroPort Scientific has current market cap of $2B, and enterprise value of $3B.

Market Cap Evolution


MicroPort Scientific's stock price is $0.97.

MicroPort Scientific share price increased by 1.1% in the last 30 days, and decreased by 13.2% in the last year.

MicroPort Scientific has an EPS (earnings per share) of $0.03.

See more trading valuation data for MicroPort Scientific
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$2B-0.9%1.1%-19.9%-13.2%$0.03

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

MicroPort Scientific Valuation Multiples

MicroPort Scientific trades at 2.3x EV/Revenue multiple, and 14.0x EV/EBITDA.

See NTM and 2027E valuation multiples for MicroPort Scientific

EV / Revenue (LTM)


MicroPort Scientific Financial Valuation Multiples

As of June 3, 2026, MicroPort Scientific has market cap of $2B and EV of $3B.

MicroPort Scientific has a P/E ratio of 28.8x.

LTMLast FY202320242025202620272028
EV/Revenue2.3x2.4x2.8x2.6x2.7x
EV/EBITDA14.0x16.6x(6.9x)71.6x110.8x
EV/EBIT140.2x(123.9x)(7.1x)(22.5x)(48.5x)
EV/Gross Profit4.0x4.8x5.0x4.6x4.8x
P/E28.8x38.2x(3.9x)(8.7x)38.2x
EV/FCFn/m(81.1x)(6.1x)(16.7x)(81.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified MicroPort Scientific Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

MicroPort Scientific Margins & Growth Rates

MicroPort Scientific grew revenue by 7% and EBITDA by 46% in the last fiscal year.

In the most recent fiscal year, MicroPort Scientific reported gross margin of 50%, EBITDA margin of 14%, and net margin of 4%.

See estimated margins and future growth rates for MicroPort Scientific

MicroPort Scientific Margins

Last FY202420252026202720282029
Gross Margin50%56%56%58%
EBITDA Margin14%4%2%20%
EBIT Margin(2%)(11%)(5%)6%
Net Margin4%(21%)5%7%
FCF Margin(3%)(15%)(3%)12%

MicroPort Scientific Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%8%(4%)19%
Gross Profit Growth24%8%(4%)24%
EBITDA Growth46%(110%)(35%)870%
EBIT Growth(446%)(69%)(54%)(236%)
Net Profit Growth78%(55%)(123%)78%
FCF Growth(531%)(63%)(79%)(531%)

Data powered by FactSet, Inc. and Morningstar, Inc.

MicroPort Scientific Operational KPIs

MicroPort Scientific's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

MicroPort Scientific's Rule of 40 is 38% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

MicroPort Scientific's Rule of X is 66% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for MicroPort Scientific
LTMLast FY202320242025202620272028
Rule of 4027%38%---
Bessemer Rule of X43%66%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue30%29%35%29%30%
G&A Expenses to Revenue18%19%22%18%17%
R&D Expenses to Revenue13%13%40%21%14%
Opex to Revenue-55%95%67%61%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

MicroPort Scientific Competitors

MicroPort Scientific competitors include NovoCure, AddLife, Bausch Health, MicroPort, Embla Medical, Oxford Nanopore Technologies, Draegerwerk, Fukuda Denshi, MicroPort EP and Beijing Balance Medical.

Most MicroPort Scientific public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
NovoCure2.5x2.4x(47.6x)(73.6x)
AddLife2.0x2.0x11.9x12.2x
Bausch Health2.1x2.1x6.0x5.8x
MicroPort8.0x7.4x14.7x13.8x
Embla Medical2.4x2.3x12.0x11.5x
Oxford Nanopore Technologies5.0x4.5x(12.9x)(15.0x)
Draegerwerk0.4x0.4x3.9x3.8x
Fukuda Denshi1.8x1.8x6.6x-

This data is available for Pro users. Sign up to see all MicroPort Scientific competitors and their valuation data.

Start Free Trial

Investments by MicroPort Scientific

MicroPort Scientific has invested in 3 companies to date.

Latest investment by MicroPort Scientific was on May 6th 2020. MicroPort Scientific invested in NDR Medical in their $6M Series A round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by MicroPort Scientific

NDR Medical
Robocath
Promaxo
Promaxo
Description
NDR Medical is a medical device company developing image-guided robotic systems for surgical needle targeting. Its platform enables precise punctures in lungs, kidneys, pancreas, and spine during procedures. Based in Quebec, Canada, NDR integrates robotics with imaging for enhanced accuracy in interventional radiology worldwide.
Robocath is a Rouen-based medical robotics company developing systems for cardiovascular interventions. Founded in 2009, it markets R-One, a robotic platform for precise coronary angioplasty compatible with leading cath lab devices and consumables to enhance procedural safety.
Promaxo is a medical technology company developing MRI-compatible robotics and machine learning systems for in-office procedures. Protected by over 55 patents its products include guidance systems disposables and AI-based tissue characterization tools targeting interventional radiology. San Diego-based the firm commercializes customer-centric MRI enhancements for patient care.
Promaxo is a medical technology company developing MRI-compatible robotics and machine learning systems for in-office procedures. Protected by over 55 patents its products include guidance systems disposables and AI-based tissue characterization tools targeting interventional radiology. San Diego-based the firm commercializes customer-centric MRI enhancements for patient care.
HQ CountrySingaporeFranceUnited StatesUnited States
HQ City
Singapore
Rouen
San Francisco, CA
San Francisco, CA
Deal Date6 May 202029 Apr 202011 Apr 201829 Sep 2017
RoundSeries ASeries CSeries ASeries A
Raised$6M$44M$2M$4M
InvestorsMicroPort ScientificAnaxago; CS GROUP; MicroPort Scientific; Tusholdings; Zhejiang Silk Road FundAlmond Tree Capital Fund; MicroPort Scientific; RocSon Medtech FundMicroPort Scientific
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all MicroPort Scientific investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About MicroPort Scientific

When was MicroPort Scientific founded?MicroPort Scientific was founded in 1998.
Where is MicroPort Scientific headquartered?MicroPort Scientific is headquartered in China.
How many employees does MicroPort Scientific have?As of today, MicroPort Scientific has over 6K employees.
Who is the CEO of MicroPort Scientific?MicroPort Scientific's CEO is Zhaohua Chang.
Is MicroPort Scientific publicly listed?Yes, MicroPort Scientific is a public company listed on HKEX.
What is the stock symbol of MicroPort Scientific?MicroPort Scientific trades under 00853 ticker.
When did MicroPort Scientific go public?MicroPort Scientific went public in 2010.
Who are competitors of MicroPort Scientific?MicroPort Scientific main competitors include NovoCure, AddLife, Bausch Health, MicroPort, Embla Medical, Oxford Nanopore Technologies, Draegerwerk, Fukuda Denshi, MicroPort EP, Beijing Balance Medical.
What is the current market cap of MicroPort Scientific?MicroPort Scientific's current market cap is $2B.
What is the current revenue of MicroPort Scientific?MicroPort Scientific's last 12 months revenue is $1B.
What is the current revenue growth of MicroPort Scientific?MicroPort Scientific revenue growth (NTM/LTM) is 10%.
What is the current EV/Revenue multiple of MicroPort Scientific?Current revenue multiple of MicroPort Scientific is 2.3x.
What is the current EBITDA of MicroPort Scientific?MicroPort Scientific's last 12 months EBITDA is $190M.
What is MicroPort Scientific's EBITDA margin?MicroPort Scientific's last 12 months EBITDA margin is 17%.
What is the current EV/EBITDA multiple of MicroPort Scientific?Current EBITDA multiple of MicroPort Scientific is 14.0x.
What is the current FCF of MicroPort Scientific?MicroPort Scientific's last 12 months FCF is $7M.
What is MicroPort Scientific's FCF margin?MicroPort Scientific's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of MicroPort Scientific?Current FCF multiple of MicroPort Scientific is 364.2x.
How many companies MicroPort Scientific has acquired to date?MicroPort Scientific hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies MicroPort Scientific has invested to date?As of June 2026, MicroPort Scientific has invested in 3 companies.
What was the last MicroPort Scientific investment?On 6th May 2020 MicroPort Scientific invested in NDR Medical, participating in a $6M Series A round.
In what companies MicroPort Scientific invested in?MicroPort Scientific invested in Robocath, NDR Medical, and Promaxo.

See public comps similar to MicroPort Scientific

Lists including MicroPort Scientific

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial